“Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors ”. The Review of Diabetic Studies , vol. 5, no. 2, Aug. 2023, https://diabeticstudies.org/index.php/RDS/article/view/287.